References
- Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 2013;45:1-14. https://doi.org/10.4143/crt.2013.45.1.1
- Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat 2014;46:109-23. https://doi.org/10.4143/crt.2014.46.2.109
- Jung KW, Won YJ, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat 2015;47:127-41. https://doi.org/10.4143/crt.2015.060
- Oh CM, Won YJ, Jung KW, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat 2016;48:436-50. https://doi.org/10.4143/crt.2016.089
- Lee TJ, Kim S, Cho HJ, Lee JH. The incidence of thyroid cancer is affected by the characteristics of a healthcare system. J Korean Med Sci 2012;27:1491-8. https://doi.org/10.3346/jkms.2012.27.12.1491
- Suh M, Choi KS, Park B, et al. Trends in cancer screening rates among Korean men and women: results of the Korean National Cancer Screening Survey, 2004-2013. Cancer Res Treat 2016;48:1-10. https://doi.org/10.4143/crt.2014.204
- Yoo SY, Kim MS, Ji YH, Cho CK, Yang KM, You HJ. Statistics for Department of Radiation Oncology (1999-2001). J Korean Soc Ther Radiol Oncol 2004;22:234-6.
- Kim MS, Ji YH, You SY, Cho CK, Yang KM, Ryu HJ. National statistics of radiation oncology in Korea (2002-2004). J Korean Soc Ther Radiol Oncol 2006;24:77-80.
- Kim MS, Ji YH, You SY, et al. National statistics of radiation oncology in Korea (2005). J Korean Soc Ther Radiol Oncol 2006;24:207-9.
- Ji YH, Kim MS, You SY, You DH, Choi MS, Jung HJ. National statistics of radiation oncology in Korea (2006). J Korean Soc Ther Radiol Oncol 2008;26:131-3.
- Kang JK, Kim MS, Jang WI, et al. The clinical status of radiation therapy in Korea in 2009 and 2013. Cancer Res Treat 2015 Dec 14 [Epub]. http://dx.doi.org/10.4143/crt.2015.370.
- Jung KW, Park S, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat 2012;44:11-24. https://doi.org/10.4143/crt.2012.44.1.11
- Delaney G, Jacob S, Featherstone C, Barton M. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 2005;104:1129-37. https://doi.org/10.1002/cncr.21324
- Jaen Olasolo J, Alonso Redondo E, Exposito Hernandez J, de las Penas Cabrera MD, Cabrera Roldan P. Evidence-based estimation and radiotherapy utilisation rate in Andalusia. Clin Transl Oncol 2007;9:789-96. https://doi.org/10.1007/s12094-007-0141-1
- Barton MB, Jacob S, Shafiq J, et al. Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012. Radiother Oncol 2014;112:140-4. https://doi.org/10.1016/j.radonc.2014.03.024
- Borras JM, Lievens Y, Dunscombe P, et al. The optimal utilization proportion of external beam radiotherapy in European countries: an ESTRO-HERO analysis. Radiother Oncol 2015;116:38-44. https://doi.org/10.1016/j.radonc.2015.04.018
- Rosenblatt E, Barton M, Mackillop W, et al. Optimal radiotherapy utilisation rate in developing countries: an IAEA study. Radiother Oncol 2015;116:35-7. https://doi.org/10.1016/j.radonc.2015.06.012
- Mackillop WJ, Kong W, Brundage M, et al. A comparison of evidence-based estimates and empirical benchmarks of the appropriate rate of use of radiation therapy in Ontario. Int J Radiat Oncol Biol Phys 2015;91:1099-107. https://doi.org/10.1016/j.ijrobp.2014.11.026
Cited by
- Recurrence outcomes after omission of postoperative radiotherapy following breast-conserving surgery for ductal carcinoma in situ of the breast: a multicenter, retrospective study in Korea (KROG 16-02 vol.162, pp.1, 2017, https://doi.org/10.1007/s10549-017-4111-1
- Quality assurance for a multicenter Phase II study of stereotactic ablative radiotherapy for hepatocellular carcinoma ≤5 cm: a planning dummy run vol.47, pp.6, 2016, https://doi.org/10.1093/jjco/hyw156
- Selective Radiation Therapy for Ductal Carcinoma In Situ Following Breast-Conserving Surgery According to Age and Margin Width: Korean Radiation Oncology Group 11-04 and 16-02 Studies vol.20, pp.4, 2016, https://doi.org/10.4048/jbc.2017.20.4.327
- Incorporating Risk Factors to Identify the Indication of Post-mastectomy Radiotherapy in N1 Breast Cancer Treated with Optimal Systemic Therapy: A Multicenter Analysis in Korea (KROG 14-23) vol.49, pp.3, 2017, https://doi.org/10.4143/crt.2016.405
- Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer vol.104, pp.7, 2016, https://doi.org/10.1002/bjs.10502
- Gamma Evaluation with Portal Dosimetry for Volumetric Modulated Arc Therapy and Intensity-Modulated Radiation Therapy vol.28, pp.2, 2017, https://doi.org/10.14316/pmp.2017.28.2.61
- Possible benefits from post-mastectomy radiotherapy in node-negative breast cancer patients: a multicenter analysis in Korea (KROG 14-22) vol.8, pp.35, 2016, https://doi.org/10.18632/oncotarget.16241
- Intensity-modulated radiotherapy for hepatocellular carcinoma: dosimetric and clinical results vol.8, pp.35, 2017, https://doi.org/10.18632/oncotarget.19219
- A Pilot Study of the Scanning Beam Quality Assurance Using Machine Log Files in Proton Beam Therapy vol.28, pp.3, 2016, https://doi.org/10.14316/pmp.2017.28.3.129
- Valproic Acid Sensitizes Hepatocellular Carcinoma Cells to Proton Therapy by Suppressing NRF2 Activation vol.7, pp.None, 2016, https://doi.org/10.1038/s41598-017-15165-3
- Value of imaging study in predicting pelvic lymph node metastases of uterine cervical cancer vol.35, pp.4, 2016, https://doi.org/10.3857/roj.2017.00206
- Malignant and borderline phyllodes tumors of the breast: a multicenter study of 362 patients (KROG 16-08) vol.171, pp.2, 2018, https://doi.org/10.1007/s10549-018-4838-3
- Which Patients with Left Breast Cancer Should be Candidates for Heart-Sparing Radiotherapy? vol.21, pp.2, 2018, https://doi.org/10.4048/jbc.2018.21.2.206
- Patterns of Practice in Radiotherapy for Breast Cancer in Korea vol.21, pp.3, 2016, https://doi.org/10.4048/jbc.2018.21.e37
- A Survey of Radiation Therapy Utilization in Korea from 2010 to 2016: Focusing on Use of Intensity-Modulated Radiation Therapy vol.33, pp.9, 2018, https://doi.org/10.3346/jkms.2018.33.e67
- The Clinical Utilization of Radiation Therapy in Korea between 2011 and 2015 vol.50, pp.2, 2016, https://doi.org/10.4143/crt.2017.096
- Estimation of the medical need for carbon-ion radiotherapy in Korea vol.59, pp.5, 2016, https://doi.org/10.1093/jrr/rry046
- Breast Conservation Therapy Versus Mastectomy in Patients with T1-2N1 Triple-Negative Breast Cancer: Pooled Analysis of KROG 14-18 and 14-23 vol.50, pp.4, 2018, https://doi.org/10.4143/crt.2017.575
- Clinical utilization of radiation therapy in Korea, 2016 vol.61, pp.2, 2016, https://doi.org/10.1093/jrr/rrz095